🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Preop Laxatives in Robotic Urologic Surgery

RecruitingPhase 4Ages 30 Years - 100 YearsAllChad R. Tracy
NCT05805436 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Minimally-invasive surgery, either laparoscopic or robotic, is commonly used in urology. Several urologic procedures including prostatectomy, radical nephrectomy, and partial nephrectomy are now commonly performed robotically. Patients undergoing these procedures often have delayed return of bowel function and persistent gastrointestinal symptoms including nausea/vomiting, abdominal distension, and bloating for several days to weeks after surgery. Postoperative stool softeners and laxatives are routinely used in an effort to minimize these symptoms, with varying degrees of success. The aim of this study will be to evaluate whether the use of a preoperative osmotic laxative will be beneficial in improving recovery of bowel function and alleviating postoperative gastrointestinal complaints in patients undergoing these procedures. Patients will be randomized to either receive or not receive

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria: -Patients 30 years or older undergoing robotic-assisted laparoscopic radical prostatectomy, transperitoneal radical nephrectomy, or transperitoneal partial nephrectomy Exclusion criteria: * Patients under 30 years old * Patients with a contraindication to receiving polyethylene glycol or other forms of laxatives * People who regularly take Miralax * Patients undergoing retroperitoneal radical or partial nephrectomy * Patients with severe ulcerative colitis or Crohn's disease * Patients with intestinal diversions (colostomy, ileostomy) * Patients with prior abdominal or pelvic radiation * Patients who will not follow up with UIHC postoperatively * Patients who are incarcerated
💊

What it tests

  • Polyethylene Glycol 3350
📍

Where

1 site
University of Iowa Hospitals & Clinics
Iowa City, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy